Dr. Christie Ballantyne and Dr. Adam T Phillips Discuss: ASCVD Reduction and Lipid Lowering Therapies November 18, 2019 Disclosures: TBA
Dr. Jennifer Robinson and Dr. C.Michael Gibson Discuss: The Evolving Landscape of PCSK9 Inhibitors November 18, 2019 Disclosures: TBA
Prof. Philip Aylward Presents: AHA 2019 Wrap-Up from the Perspective of the Pacific Rim November 18, 2019 Disclosures: TBA
Ms. Katherine Wilemon, Founder and CEO of the FH Foundation, and Dr. C. Michael Gibson Discuss: Familial Hypercholesterolemia – A Deep Dive – Sponsored by an independent educational grant from The Medicines Company November 18, 2019 Disclosures: TBA
Dr. George Dangas and Dr. C. Michael Gibson Discuss: GALILEO: Global Comparison of a Rivaroxaban-Based Antithrombotic Strategy versus an Antiplatelet-Based Strategy After Transcathether Aortic Valve Replacement to Optimize Clinical Outcomes: Primary Results November 17, 2019 Disclosures: TBA
Dr. Matthew Budoff and Dr. C Michael Gibson Discuss: EVAPORATE Study: Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides (200-499mg/dl) on Statin Therapy November 17, 2019 Disclosures: TBA
Dr. Sripal Bangalore and Dr. C Michael Gibson Discuss: International Study of Comparative Health Effectiveness With Medical and Invasive Approaches- Chronic Kidney Disease (ISCHEMIA-CKD): Primary Results of Clinical Outcomes November 17, 2019 Disclosures: TBA
Dr. Kausik Ray and Dr. C Michael Gibson Discuss: BETonMACE: Effect of BET Protein Inhibition With Apabetalone on Cardiovascular Outcomes in Patients With Acute Coronary Syndrome and Diabetes – Results of the BETonMACE Trial November 17, 2019 Disclosures: TBA
Dr. Natalia Pinilla-Echeverri and Dr. Arzu Kalayci: COMPLETE: Non-Culprit Lesion Plaque Morphology in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Trial Optical Coherence Tomography (OCT) Substudy November 17, 2019 Disclosures: TBA
Dr. R. Scott Wright and Dr. C. Michael Gibson Discuss: PHASE 3 ORION-10: Safety and Efficacy of Inclisiran in Patients With ASCVD and Elevated LDL Cholesterol – Results From the Phase 3 ORION-10 Trial – Sponsored by an independent educational grant from The Medicines Company November 17, 2019 Disclosures: TBA
